Ethambutol-induced optic neuropathy is a well-known and devastating complication of
ethambutol therapy. It may occur in approximately 1% of patients taking ethambutol at the …

This article describes the main visual electrodiagnostic tests relevant to neuro-
ophthalmology practice, including the visual evoked potential (VEP), and the full-field …

Background: There is a group of optic neuropathies of either genetic or acquired origin
characterized by similar clinical manifestations with preferential involvement of the …

Nervous system toxicity with current antituberculosis pharmacotherapy is relatively
uncommon, although the frequency of the usage of antituberculosis therapy requires that …

Visual field assessment is important in the evaluation of lesions involving the visual
pathways and should be performed at baseline and periodically in the follow-up. Standard …

Delay in diagnosis or treatment of ocular tuberculosis can result in loss of vision. However,
due to the fact that early diagnosis is rarely achieved, there are still a broad variety of …

Ethambutol use may lead to permanent vision loss by inducing a dose-and duration-
dependent optic neuropathy. This has been of concern to ophthalmologists and physicians …

Aim To investigate the risk factors and comorbidities associated with ethambutol-induced
optic neuropathy (EON). Method Using the Taiwan Longitudinal Health Insurance Database …

Ethambutol (EMB), an effective first-line antituberculosis agent, can cause serious visual
impairment or irreversible vision loss in a significant number of patients. However, the …

Context: Tuberculosis in developed countries is on the rise, and the main treatment
ethambutol is known to induce ocular toxicity. However, to date, there are unknown tests or …